FindTrial
Sign In

Pediarix

BIOLOGICAL8 trials

Sponsors

GlaxoSmithKline, Pfizer

Conditions

Acellular PertussisDiphtheriaHaemophilus Influenzae Type bHealthyHepatitis BInfections, MeningococcalNeisseria MeningitidisPoliomyelitis

Phase 2

Comparison of GSKBiologicals' Hib-MenCY-TT Vaccine vs Licensed Hib Conjugate or Meningococcal Vaccine
CompletedNCT00129129
GlaxoSmithKlineHaemophilus Influenzae Type b, Neisseria Meningitidis
Start: 2004-08-01End: 2006-03-29Updated: 2018-08-24

Phase 3

Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate Vaccine
CompletedNCT00289783
GlaxoSmithKlineHaemophilus Influenzae Type b, Neisseria Meningitidis
Start: 2006-02-22End: 2008-02-26Updated: 2018-08-24
Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants
CompletedNCT02096263
GlaxoSmithKlineAcellular Pertussis, Diphtheria, Haemophilus Influenzae Type b +3
Start: 2014-04-16End: 2015-11-13Updated: 2019-11-27
This Study Will Evaluate the Immunogenicity, Reactogenicity and Safety of the Routine Infant Vaccines Pediarix®, Hiberix® and Prevenar 13® When Co-administered With GlaxoSmithKline (GSK) Biologicals' Liquid Human Rotavirus Vaccine (HRV) as Compared to GSK's Licensed Lyophilized Vaccine
CompletedNCT03207750
GlaxoSmithKlineRotavirus Infection, Rotavirus Vaccines
Start: 2017-09-14End: 2019-03-01Updated: 2020-12-29
Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine Administered Concomitantly With Routine Infant Vaccines to Healthy Infants
CompletedNCT03621670
GlaxoSmithKlineInfections, Meningococcal
Start: 2018-07-27End: 2024-12-27Updated: 2026-02-10
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
RecruitingNCT07160244
PfizerHealthy
Start: 2025-08-25End: 2029-03-02Target: 6000Updated: 2026-02-04

Unknown Phase

Post-marketing Safety Study of GSK Biological's Pediarix™ Vaccine
CompletedNCT00146835
GlaxoSmithKlineAcellular Pertussis, Diphtheria, Hepatitis B +2
Start: 2003-04-30End: 2006-06-30Updated: 2014-01-13
Duration of Protection: GSK DTaP Vaccines
CompletedNCT02447978
GlaxoSmithKlineAcellular Pertussis, Diphtheria, Tetanus
Start: 2015-02-28End: 2015-06-30Updated: 2015-11-02

Related Papers

408. Safety and Immunogenicity of Meningococcal Serogroup B Vaccine (4CMenB) and 13-Valent Pneumococcal Vaccine (PCV13) Administered Concomitantly with Routine Infant Vaccines (RIVs) to Healthy United States (US) Infants: A Randomized Controlled Study
Open Forum Infectious Diseases2026-01-01
Concomitant administration of a liquid formulation of human rotavirus vaccine (porcine circovirus-free) with routine childhood vaccines in infants in the United States: Results from a phase 3, randomized trial.
2020-10-172 citations
1385. Concomitant Administration of Liquid Porcine Circovirus-free Human Rotavirus Vaccine with Routine Pediatric Vaccines Does Not Impact Immune Responses in Infants: Results from a Phase 3, Randomized Trial in the United States
Open Forum Infectious Diseases2020-10-01
Immunogenicity and safety following primary and booster vaccination with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus and <i>Haemophilus influenzae</i> type b vaccine: a randomized trial in the United States
Human Vaccines & Immunotherapeutics2018-11-2016 citations
Waning protection following 5 doses of a 3-component diphtheria, tetanus, and acellular pertussis vaccine
Vaccine2017-05-1342 citations
Immunogenicity and safety of measles-mumps-rubella and varicella vaccines coadministered with a fourth dose of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine in toddlers: a pooled analysis of randomized trials.
2012-08-017 citations
The safety profile of Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y tetanus toxoid conjugate vaccine (HibMenCY).
2012-02-139 citations